ADME LIMS suitable for unlabelled compound data
The latest pharmaceutical company to install LabLogic’s Debra LIMS will be using it to dose cold, unlabelled compounds, taking advantage of the program’s facilities for designing and preparing formulations, dosing, and collecting sample times.
Protocol information including sample barcodes will be passed to Thermo’s Watson LIMS, and concentration data imported back to Debra.
As part of the implementation, LabLogic has introduced a new treatment method that has features for cassette dosing of multiple compounds. Improvements are also being made to simplify dosing of subjects by volume, and a new report is being added to summarise all clinical observations made in a study.
“The company needed to replace an in-house program to manage its in-life group performing bioanalytical studies and found that Debra was an affordable match with its requirements,” said LabLogic systems director Huw Loaring.
“Many of our customers no longer perform in-house the ADME radio-labelled studies that Debra was originally developed for; but they are finding it sufficiently versatile to work with many different protocol types.”
